Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Fragment-based Drug Discovery
Revenue, means the sales value of Fragment-based Drug Discovery
This report studies sales (consumption) of Fragment-based Drug Discovery in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Astex Pharmaceuticals
Alveus Pharmaceuticals Pvt. Ltd
Beactica AB
Charles River Laboratories International, Inc
Crown Bioscience, Inc
Emerald BioStructures, Inc
Evotec AG
Kinetic Discovery Limited
Proteros Fragments GmbH
Sprint Bioscience
Structure Based Design, Inc
Sygnature Discovery
Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Fragment-based Drug Discovery in these regions, from 2011 to 2021 (forecast), like
Germany
France
UK
Italy
Spain
Russia
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
NMR Spectroscopy
DSF Assay
Fluorescence Polarization (FP)
Isothermal Titration Calorimetry (ITC)
X-ray Crystallography
Split by applications, this report focuses on sales, market share and growth rate of Fragment-based Drug Discovery in each application, can be divided into
Biopharmaceutical Companies
CROs
Academic and Research Institutions
1 Fragment-based Drug Discovery Overview
1.1 Product Overview and Scope of Fragment-based Drug Discovery
1.2 Classification of Fragment-based Drug Discovery
1.2.1 NMR Spectroscopy
1.2.2 DSF Assay
1.2.3 Fluorescence Polarization (FP)
1.2.4 Isothermal Titration Calorimetry (ITC)
1.2.5 X-ray Crystallography
1.3 Applications of Fragment-based Drug Discovery
1.3.1 Biopharmaceutical Companies
1.3.2 CROs
1.3.3 Academic and Research Institutions
1.4 Fragment-based Drug Discovery Market by Regions
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Italy Status and Prospect (2011-2021)
1.4.5 Spain Status and Prospect (2011-2021)
1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Fragment-based Drug Discovery (2011-2021)
1.5.1 Europe Fragment-based Drug Discovery Sales, Revenue and Price (2011-2021)
1.5.2 Europe Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
1.5.3 Europe Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
2 Europe Fragment-based Drug Discovery by Manufacturers, Type and Application
2.1 Europe Fragment-based Drug Discovery Market Competition by Manufacturers
2.1.1 Europe Fragment-based Drug Discovery Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Fragment-based Drug Discovery Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Fragment-based Drug Discovery (Volume and Value) by Type
2.2.1 Europe Fragment-based Drug Discovery Sales and Market Share by Type (2011-2021)
2.2.2 Europe Fragment-based Drug Discovery Revenue and Market Share by Type (2011-2021)
2.3 Europe Fragment-based Drug Discovery (Volume and Value) by Regions
2.3.1 Europe Fragment-based Drug Discovery Sales and Market Share by Regions (2011-2021)
2.3.2 Europe Fragment-based Drug Discovery Revenue and Market Share by Regions (2011-2021)
2.4 Europe Fragment-based Drug Discovery (Volume) by Application
3 Germany Fragment-based Drug Discovery (Volume, Value and Sales Price)
3.1 Germany Fragment-based Drug Discovery Sales and Value (2011-2021)
3.1.1 Germany Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
3.1.2 Germany Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
3.1.3 Germany Fragment-based Drug Discovery Sales Price Trend (2011-2021)
3.2 Germany Fragment-based Drug Discovery Sales and Market Share by Manufacturers
3.3 Germany Fragment-based Drug Discovery Sales and Market Share by Type
3.4 Germany Fragment-based Drug Discovery Sales and Market Share by Applications
4 UK Fragment-based Drug Discovery (Volume, Value and Sales Price)
4.1 UK Fragment-based Drug Discovery Sales and Value (2011-2021)
4.1.1 UK Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
4.1.2 UK Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
4.1.3 UK Fragment-based Drug Discovery Sales Price Trend (2011-2021)
4.2 UK Fragment-based Drug Discovery Sales and Market Share by Manufacturers
4.3 UK Fragment-based Drug Discovery Sales and Market Share by Type
4.4 UK Fragment-based Drug Discovery Sales and Market Share by Applications
5 France Fragment-based Drug Discovery (Volume, Value and Sales Price)
5.1 France Fragment-based Drug Discovery Sales and Value (2011-2021)
5.1.1 France Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
5.1.2 France Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
5.1.3 France Fragment-based Drug Discovery Sales Price Trend (2011-2021)
5.2 France Fragment-based Drug Discovery Sales and Market Share by Manufacturers
5.3 France Fragment-based Drug Discovery Sales and Market Share by Type
5.4 France Fragment-based Drug Discovery Sales and Market Share by Applications
6 Italy Fragment-based Drug Discovery (Volume, Value and Sales Price)
6.1 Italy Fragment-based Drug Discovery Sales and Value (2011-2021)
6.1.1 Italy Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
6.1.2 Italy Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
6.1.3 Italy Fragment-based Drug Discovery Sales Price Trend (2011-2021)
6.2 Italy Fragment-based Drug Discovery Sales and Market Share by Manufacturers
6.3 Italy Fragment-based Drug Discovery Sales and Market Share by Type
6.4 Italy Fragment-based Drug Discovery Sales and Market Share by Applications
7 Russia Fragment-based Drug Discovery (Volume, Value and Sales Price)
7.1 Russia Fragment-based Drug Discovery Sales and Value (2011-2021)
7.1.1 Russia Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
7.1.2 Russia Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
7.1.3 Russia Fragment-based Drug Discovery Sales Price Trend (2011-2021)
7.2 Russia Fragment-based Drug Discovery Sales and Market Share by Manufacturers
7.3 Russia Fragment-based Drug Discovery Sales and Market Share by Type
7.4 Russia Fragment-based Drug Discovery Sales and Market Share by Applications
8 Spain Fragment-based Drug Discovery (Volume, Value and Sales Price)
8.1 Spain Fragment-based Drug Discovery Sales and Value (2011-2021)
8.1.1 Spain Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
8.1.2 Spain Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
8.1.3 Spain Fragment-based Drug Discovery Sales Price Trend (2011-2021)
8.2 Spain Fragment-based Drug Discovery Sales and Market Share by Manufacturers
8.3 Spain Fragment-based Drug Discovery Sales and Market Share by Type
8.4 Spain Fragment-based Drug Discovery Sales and Market Share by Applications
9 Europe Fragment-based Drug Discovery Manufacturers Analysis
9.1 Astex Pharmaceuticals
9.1.1 Company Basic Information,Manufacturing Base and Competitors
9.1.2 Fragment-based Drug Discovery Product Type and Technology
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Fragment-based Drug Discovery Sales, Revenue, Price of Astex Pharmaceuticals (2015 and 2016)
9.2 Alveus Pharmaceuticals Pvt. Ltd
9.2.1 Company Basic Information,Manufacturing Base and Competitors
9.2.2 Fragment-based Drug Discovery Product Type and Technology
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Fragment-based Drug Discovery Sales, Revenue, Price of Alveus Pharmaceuticals Pvt. Ltd (2015 and 2016)
9.3 Beactica AB
9.3.1 Company Basic Information,Manufacturing Base and Competitors
9.3.2 Fragment-based Drug Discovery Product Type and Technology
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Fragment-based Drug Discovery Sales, Revenue, Price of Beactica AB (2015 and 2016)
9.4 Charles River Laboratories International, Inc
9.4.1 Company Basic Information,Manufacturing Base and Competitors
9.4.2 Fragment-based Drug Discovery Product Type and Technology
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 Fragment-based Drug Discovery Sales, Revenue, Price of Charles River Laboratories International, Inc (2015 and 2016)
9.5 Crown Bioscience, Inc
9.5.1 Company Basic Information,Manufacturing Base and Competitors
9.5.2 Fragment-based Drug Discovery Product Type and Technology
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Fragment-based Drug Discovery Sales, Revenue, Price of Crown Bioscience, Inc (2015 and 2016)
9.6 Emerald BioStructures, Inc
9.6.1 Company Basic Information,Manufacturing Base and Competitors
9.6.2 Fragment-based Drug Discovery Product Type and Technology
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Fragment-based Drug Discovery Sales, Revenue, Price of Emerald BioStructures, Inc (2015 and 2016)
9.7 Evotec AG
9.7.1 Company Basic Information,Manufacturing Base and Competitors
9.7.2 Fragment-based Drug Discovery Product Type and Technology
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Fragment-based Drug Discovery Sales, Revenue, Price of Evotec AG (2015 and 2016)
9.8 Kinetic Discovery Limited
9.8.1 Company Basic Information,Manufacturing Base and Competitors
9.8.2 Fragment-based Drug Discovery Product Type and Technology
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 Fragment-based Drug Discovery Sales, Revenue, Price of Kinetic Discovery Limited (2015 and 2016)
9.9 Proteros Fragments GmbH
9.9.1 Company Basic Information,Manufacturing Base and Competitors
9.9.2 Fragment-based Drug Discovery Product Type and Technology
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Fragment-based Drug Discovery Sales, Revenue, Price of Proteros Fragments GmbH (2015 and 2016)
9.10 Sprint Bioscience
9.10.1 Company Basic Information,Manufacturing Base and Competitors
9.10.2 Fragment-based Drug Discovery Product Type and Technology
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Fragment-based Drug Discovery Sales, Revenue, Price of Sprint Bioscience (2015 and 2016)
9.11 Structure Based Design, Inc
9.11.1 Company Basic Information,Manufacturing Base and Competitors
9.11.2 Fragment-based Drug Discovery Product Type and Technology
9.11.2.1 Type I
9.11.2.2 Type II
9.11.3 Fragment-based Drug Discovery Sales, Revenue, Price of Structure Based Design, Inc (2015 and 2016)
9.12 Sygnature Discovery
9.12.1 Company Basic Information,Manufacturing Base and Competitors
9.12.2 Fragment-based Drug Discovery Product Type and Technology
9.12.2.1 Type I
9.12.2.2 Type II
9.12.3 Fragment-based Drug Discovery Sales, Revenue, Price of Sygnature Discovery (2015 and 2016)
10 Fragment-based Drug Discovery Technology and Development Trend
10.1 Fragment-based Drug Discovery Technology Analysis
10.2 Fragment-based Drug Discovery Technology Development Trend
11 Research Findings and Conclusion
Figure Picture of Fragment-based Drug Discovery
Table Classification of Fragment-based Drug Discovery
Figure Europe Sales Market Share of Fragment-based Drug Discovery by Types in 2015
Figure NMR Spectroscopy Picture
Figure DSF Assay Picture
Figure Fluorescence Polarization (FP) Picture
Figure Isothermal Titration Calorimetry (ITC) Picture
Figure X-ray Crystallography Picture
Table Applications of Fragment-based Drug Discovery
Figure Europe Sales Market Share of Fragment-based Drug Discovery by Applications in 2015
Figure Biopharmaceutical Companies Examples
Figure CROs Examples
Figure Academic and Research Institutions Examples
Figure Germany Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure France Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure UK Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Italy Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Spain Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Russia Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Table Europe Fragment-based Drug Discovery Sales, Revenue and Price (2011-2021)
Figure Europe Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure Europe Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Table Europe Fragment-based Drug Discovery Sales of Key Manufacturers (2015 and 2016)
Table Europe Fragment-based Drug Discovery Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Fragment-based Drug Discovery Sales Share by Manufacturers
Figure 2016 Fragment-based Drug Discovery Sales Share by Manufacturers
Table Europe Fragment-based Drug Discovery Revenue by Manufacturers (2015 and 2016)
Table Europe Fragment-based Drug Discovery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Fragment-based Drug Discovery Revenue Share by Manufacturers
Table 2016 Europe Fragment-based Drug Discovery Revenue Share by Manufacturers
Table Europe Fragment-based Drug Discovery Sales and Market Share by Type (2011-2021)
Table Europe Fragment-based Drug Discovery Sales Share by Type (2011-2021)
Figure Sales Market Share of Fragment-based Drug Discovery by Type (2011-2021)
Figure Europe Fragment-based Drug Discovery Sales Growth Rate by Type (2011-2021)
Table Europe Fragment-based Drug Discovery Revenue and Market Share by Type (2011-2021)
Table Europe Fragment-based Drug Discovery Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Fragment-based Drug Discovery by Type (2011-2021)
Figure Europe Fragment-based Drug Discovery Revenue Growth Rate by Type (2011-2021)
Table Europe Fragment-based Drug Discovery Sales and Market Share by Regions (2011-2021)
Table Europe Fragment-based Drug Discovery Sales Share by Regions (2011-2021)
Figure Sales Market Share of Fragment-based Drug Discovery by Regions (2011-2021)
Figure Europe Fragment-based Drug Discovery Sales Growth Rate by Regions (2011-2021)
Table Europe Fragment-based Drug Discovery Revenue and Market Share by Regions (2011-2021)
Table Europe Fragment-based Drug Discovery Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Fragment-based Drug Discovery by Regions (2011-2021)
Figure Europe Fragment-based Drug Discovery Revenue Growth Rate by Regions (2011-2021)
Table Europe Fragment-based Drug Discovery Sales and Market Share by Application (2011-2021)
Table Europe Fragment-based Drug Discovery Sales Share by Application (2011-2021)
Figure Sales Market Share of Fragment-based Drug Discovery by Application (2011-2021)
Figure Europe Fragment-based Drug Discovery Sales Growth Rate by Application (2011-2021)
Figure Germany Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure Germany Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Germany Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table Germany Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table Germany Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table Germany Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table Germany Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table Germany Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table Germany Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Figure UK Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure UK Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure UK Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table UK Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table UK Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table UK Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table UK Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table UK Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table UK Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Figure France Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure France Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure France Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table France Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table France Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table France Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table France Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table France Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table France Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Figure Italy Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure Italy Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Italy Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table Italy Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table Italy Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table Italy Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table Italy Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table Italy Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table Italy Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Figure Russia Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure Russia Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Russia Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table Russia Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table Russia Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table Russia Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table Russia Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table Russia Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table Russia Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Figure Spain Fragment-based Drug Discovery Sales and Growth Rate (2011-2021)
Figure Spain Fragment-based Drug Discovery Revenue and Growth Rate (2011-2021)
Figure Spain Fragment-based Drug Discovery Sales Price Trend (2011-2021)
Table Spain Fragment-based Drug Discovery Sales by Manufacturers (2015 and 2016)
Table Spain Fragment-based Drug Discovery Market Share by Manufacturers (2015 and 2016)
Table Spain Fragment-based Drug Discovery Sales by Type (2015 and 2016)
Table Spain Fragment-based Drug Discovery Market Share by Type (2015 and 2016)
Table Spain Fragment-based Drug Discovery Sales by Applications (2015 and 2016)
Table Spain Fragment-based Drug Discovery Market Share by Applications (2015 and 2016)
Table Astex Pharmaceuticals Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Astex Pharmaceuticals (2015 and 2016)
Table Alveus Pharmaceuticals Pvt. Ltd Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Alveus Pharmaceuticals Pvt. Ltd (2015 and 2016)
Table Beactica AB Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Beactica AB (2015 and 2016)
Table Charles River Laboratories International, Inc Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Charles River Laboratories International, Inc (2015 and 2016)
Table Crown Bioscience, Inc Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Crown Bioscience, Inc (2015 and 2016)
Table Emerald BioStructures, Inc Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Emerald BioStructures, Inc (2015 and 2016)
Table Evotec AG Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Evotec AG (2015 and 2016)
Table Kinetic Discovery Limited Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Kinetic Discovery Limited (2015 and 2016)
Table Proteros Fragments GmbH Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Proteros Fragments GmbH (2015 and 2016)
Table Sprint Bioscience Basic Information List
Table Fragment-based Drug Discovery Sales, Revenue, Price of Sprint Bioscience (2015 and 2016)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...